Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice

Resuscitation

Volumn 83, Issue 11, 2012, Pages 1404-1410

  Mersmann, Jan ^a   Tran, Nguyen ^a   Latsch, Kathrina ^a   Habeck, Katharina ^a   Iskandar, Franziska ^a   Zimmermann, René ^a   Zacharowski, Kai ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Myocardial ischaemia; Myocardial reperfusion; PI3K AKT signalling; Toll like receptor

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TETRAZOLIUM; TOLL LIKE RECEPTOR 2; TRICIRIBINE; TROPONIN T; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ENZYME INHIBITION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; WILD TYPE;

ANDROSTADIENES; ANIMALS; MALE; MICE; MYOCARDIAL ISCHEMIA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPERFUSION INJURY; RIBONUCLEOSIDES; TOLL-LIKE RECEPTOR 2;

EID: 84867231590     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2012.04.001     Document Type: Article

References (29)

1. Favre J., Musette P., Douin-Echinard V., et al. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2007, 27:1064-1071.
2. Leemans J.C., Stokman G., Claessen N., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005, 115:2894-2903.
3. Shishido T., Nozaki N., Yamaguchi S., et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108:2905-2910.
4. Zhang J.X., Wu H.S., Wang H., et al. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005, 11:4423-4426.
5. Ziegler G., Harhausen D., Schepers C., et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 2007, 359:574-579.
6. Arslan F., Smeets M.B., O'Neill L.A., et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010, 121:80-90.
7. Mersmann J., Koch A., Tran N., et al. Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion. Crit Care Med 2010, 38:1927-1932.
8. Mersmann J., Habeck K., Latsch K., et al. Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation. Basic Res Cardiol 2011, 106:89-98.
9. Schroder N.W., Hermann C., Hamann L., et al. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003, 81:368-372.
10. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
11. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
12. Carnero A. The PKB/AKT pathway in cancer. Curr Pharm Des 2010, 16:34-44.
13. Alessi D.R., James S.R., Downes C.P., et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B[alpha]. Curr Biol 1997, 7:261-269.
14. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
15. Arbibe L., Mira J.P., Teusch N., et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000, 1:533-540.
16. Ha T., Hu Y., Liu L., et al. TLR2 ligands induce cardioprotection against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2010, 87:694-703.
17. Santos-Sierra S., Deshmukh S.D., Kalnitski J., et al. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J 2009, 28:2018-2027.
18. Hua F., Ha T., Ma J., et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 2007, 178:7317-7324.
19. Ha T., Hua F., Liu X., et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2008, 78:546-553.
20. Mersmann J., Berkels R., Zacharowski P., et al. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury. Crit Care Med 2010, 38:903-909.
21. Petzelbauer P., Zacharowski P.A., Miyazaki Y., et al. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 2005, 11:298-304.
22. Fujio Y., Nguyen T., Wencker D., et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000, 101:660-667.
23. Matsui T., Li L., del Monte F., et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999, 100:2373-2379.
24. Hönisch A., Theuring N., Ebner B., et al. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 2010, 105:155-167.
25. Cardenas M.E., Sanfridson A., Cutler N.S., et al. Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechnol 1998, 16:427-433.
26. Sayed D., He M., Hong C., et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 2010, 285:20281-20290.
27. Brunet A., Datta S.R. Greenberg ME transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001, 11:297-305.
28. Cross D.A.E., Alessi D.R., Cohen P., et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
29. Mersmann J., Latsch K., Habeck K., et al. Measure for measure - determination of infarct size in murine models of myocardial ischemia and reperfusion: a systematic review. Shock 2010, 35:449-455.